Multi- institutional alliance to develop anti-aging drugs

Drug Discovery |  News | 0 Comment | 16 Aug, 2018

The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...Read more

FDA approves Amicus' Galafold for Fabry disease

Drug Discovery |  News | 0 Comment | 13 Aug, 2018

Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medicati...Read more

Pfizer's Innovative drug IBRANCE gets China approval

Drug Discovery |  News | 0 Comment | 08 Aug, 2018

Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...Read more

DotBio successfully raises $2.3 M in seed financing

Drug Discovery |  News | 0 Comment | 07 Aug, 2018

Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanize...Read more

Medpacto inks deal with AstraZeneca

Drug Discovery |  News | 0 Comment | 02 Aug, 2018

MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto...Read more

Pfizer's Herceptin biosimilar approved in Europe

Drug Discovery |  News | 0 Comment | 31 Jul, 2018

Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cance...Read more

Nektar's back pain opioid gets approval for FDA review

Drug Discovery |  News | 0 Comment | 30 Jul, 2018

 Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NK...Read more

Agios receives nod for ivosidenib

Drug Discovery |  News | 0 Comment | 23 Jul, 2018

Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...Read more

FDA approves Pfizer's biosimilar

Drug Discovery |  News | 0 Comment | 23 Jul, 2018

Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected t...Read more

FDA approves first drug indicating treatment of smallpox

Drug Discovery |  News | 0 Comment | 16 Jul, 2018

 Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug wit...Read more

Immatics, Genmab to develop bispecific cancer immunotherapies

Drug Discovery |  News | 0 Comment | 12 Jul, 2018

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-c...Read more

FDA grants 7-year orphan drug exclusivity to Eagle

Drug Discovery |  News | 0 Comment | 09 Jul, 2018

Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seve...Read more

FDA grants ODD to OBI Pharma's lead investigational drug candidate

Drug Discovery |  News | 0 Comment | 09 Jul, 2018

OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has gra...Read more

Biogen’s Alzheimer’s drug succeeds in trial

Drug Discovery |  News | 0 Comment | 06 Jul, 2018

Singapore – Eisai and Biogen have announced positive topline results from the Phase II study with BAN2401, an...Read more

Roche announces positive results of lung cancer drug Tecentriq

Drug Discovery |  News | 0 Comment | 04 Jul, 2018

Global pharma giant recently announced that its drug candidate for cancer- the combination of Tecentriq (atezolizumab) p...Read more

Singapore institutes collaborate with ROK to develop innovative drugs

Drug Discovery |  News | 0 Comment | 03 Jul, 2018

Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research ...Read more

Lumicks teams up with AZ, UC to set up CoE

Drug Discovery |  News | 0 Comment | 28 Jun, 2018

LUMICKS, a world leader in dynamic single-molecule analysis, has partnered with AstraZeneca and the University of Cambri...Read more

Ascletis, CR Pharma sign strategic cooperation agreement

Drug Discovery |  News | 0 Comment | 27 Jun, 2018

Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parti...Read more